Showing results (1-10 of 1,695) with videos related to

Sort By:
Pageof 170
Human Genomics|September 18, 2010
ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research--an updateJoshua Xu, Reagan Kelly, Hong Fang, et al.
Chemical Research in Toxicology|June 2, 2011
Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationshipsZhichao Liu, Reagan Kelly, Hong Fang, et al.
BMC Bioinformatics|December 15, 2011
Selecting a single model or combining multiple models for microarray-based classifier development?--a comparative analysis based on large and diverse datasets generated from the MAQC-II projectMinjun Chen, Leming Shi, Reagan Kelly, et al.
BMC Bioinformatics|August 9, 2014
A phenome-guided drug repositioning through a latent variable modelHalil Bisgin, Zhichao Liu, Hong Fang, et al.
Plos Computational Biology|December 24, 2011
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)Zhichao Liu, Qiang Shi, Don Ding, et al.
BMC Bioinformatics|October 11, 2012
Investigating drug repositioning opportunities in FDA drug labels through topic modelingHalil Bisgin, Zhichao Liu, Reagan Kelly, et al.
Human Genomics|December 19, 2012
SNPTrack™ : an integrated bioinformatics system for genetic association studiesJoshua Xu, Reagan Kelly, Guangxu Zhou, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 3, 2013
Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugsMinjun Chen, Huixiao Hong, Hong Fang, et al.
BMC Bioinformatics|November 26, 2013
A systems approach for analysis of high content screening assay data with topic modelingHalil Bisgin, Minjun Chen, Yuping Wang, et al.
Drug Safety|February 20, 2025
Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabelLeihong Wu, Hong Fang, Yanyan Qu, et al.
Pageof 170